Spondylodiscitis Caused by Aspergillus Species

Area of Science:

• Infectious Diseases
• Mycology
• Spinal Surgery

Background:

• Spondylodiscitis caused by Aspergillus species is a rare, life-threatening condition.
• Lack of consensus on diagnostic criteria and optimal medical management.
• This study reviews published cases to elucidate epidemiology, patient characteristics, and treatment effectiveness.

Purpose of the Study:

• To review and analyze all published cases of Aspergillus spondylodiscitis.
• To understand the epidemiology and patient demographics.
• To evaluate the effectiveness of medical and surgical treatment options.

Main Methods:

• Comprehensive literature review of Aspergillus spondylodiscitis cases.
• Data extraction on demographics, causative Aspergillus species, diagnosis timelines, antifungal treatment (AFT), and surgical interventions.
• Analysis of treatment outcomes.

Main Results:

• 118 cases identified; mean patient age 40.6 years.
• Magnetic resonance imaging (MRI) and cultures were key diagnostic tools.
• Aspergillus fumigatus was the most common species; Amphotericin B was the preferred antifungal treatment.
• Successful outcomes in 78.8% of cases, with 65.3% undergoing surgery.

Conclusions:

• Aspergillus spondylodiscitis presents a significant clinical challenge requiring a multidisciplinary approach.
• Prolonged antifungal therapy is the established standard of care.
• Surgical intervention plays a crucial role in managing selected patients.